cyclohexanol has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cessot, A; Coriat, R; Deplanque, G; Durand, JP; Goldwasser, F; Gornet, JM; Herait, P; Mir, O; Mitry, E; Montheil, V; Raymond, E; Scotte, F; Yataghene, Y | 1 |
| Kowalski, T; Maier, C; Reinacher-Schick, A; Schlegel, U | 1 |
1 review(s) available for cyclohexanol and Colorectal Cancer
| Article | Year |
|---|---|
[Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].
Topics: Adrenergic Uptake Inhibitors; Amifostine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium Carbonate; Calcium Gluconate; Colorectal Neoplasms; Cyclohexanols; Humans; Hyperalgesia; Magnesium Chloride; Nerve Fibers; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nerves; Rats; Selective Serotonin Reuptake Inhibitors; Sodium Channels; Venlafaxine Hydrochloride | 2008 |
1 trial(s) available for cyclohexanol and Colorectal Cancer
| Article | Year |
|---|---|
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |